Completed
Systolic Hypertension in the Elderly Program (SHEP)
Led by National Heart, Lung, and Blood Institute (NHLBI) · Updated on 2016-04-15
N/A
Participants Needed
N/A
Research Sites
N/A
Total Duration
AI-Summary
What this Trial Is About
The primary objective was to assess whether long-term administration of antihypertensive therapy to elderly subjects with isolated systolic hypertension reduced the combined incidence of fatal and non-fatal stroke. The secondary objectives were to evaluate: the effect of long-term antihypertensive therapy on mortality from any cause in elderly people with isolated systolic hypertension; possible adverse effects of chronic use of antihypertensive drug treatment in this population; the effect of therapy on indices of quality-of-life; the natural history of isolated systolic hypertension in the placebo population.
CONDITIONS
Brief Title
Systolic Hypertension in the Elderly Program (SHEP)
Trial Site Locations
Site Locations not provided
Location information for this trial is currently unavailable.
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here